Protecting trade secrets is key for any company that deals with proprietary information. But according to Seyfarth Shaw partners Katherine E. Perrelli and Erik W. Weibust, those in the pharmaceutical industry face additional obstacles because they often have to communicate the data to potential investors, partners and governmental agencies.

In an entry on the firm’s Trading Secrets blog, they offer guidelines to help protect the “fruits” of research and development.